Ramelteon for Insomnia Comorbid With Asthma.

Trial Profile

Ramelteon for Insomnia Comorbid With Asthma.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 30 Apr 2013

At a glance

  • Drugs Ramelteon (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Apr 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 25 Apr 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
    • 28 Jun 2012 Primary endpoint identified as insomnia severity index as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top